{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:46:33Z","timestamp":1761511593239},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1016\/s0959-8049(00)00419-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T21:59:10Z","timestamp":1027634350000},"page":"972-978","source":"Crossref","is-referenced-by-count":29,"title":["Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens"],"prefix":"10.1016","volume":"37","author":[{"given":"C","family":"Kosmas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Tsavaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Panopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Vadiaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Stavroyianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th","family":"Kourelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Malamos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Antonopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.P","family":"Kalofonos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0959-8049(00)00419-6_BIB1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1200\/JCO.2000.18.10.2095","article-title":"Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy","volume":"18","author":"Shepherd","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vindesine alone in advanced non-small cell lung cancer","volume":"12","author":"Le Chevalier","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1634\/theoncologist.4-3-241","article-title":"Gemcitabine","volume":"4","author":"Sandler","year":"1999","journal-title":"The Oncologist"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2000.18.3.623","article-title":"Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin","volume":"18","author":"Bonomi","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1200\/JCO.1995.13.3.645","article-title":"Phase II study of docetaxel (Taxotere) for advanced or metastatic platinum-refractory non-small cell lung cancer","volume":"13","author":"Fossella","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1200\/JCO.2000.18.1.131","article-title":"Activity of docetaxel in platinum-treated non-small-cell lung cancer","volume":"18","author":"Gandara","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB7","unstructured":"Garfield DH, Dakhil SR, Whittaker TL, Keller AM. Phase II randomized multicenter trial of two dose schedules of gemcitabine as second-line therapy in patients with advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 1998, 17, 484a (abstr 1863)."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB8","unstructured":"Rosvold E, Langer CJ, Scholder R, Millenson M, Reimet E, Kreamer K. Salvage therapy with gemcitabine in advanced non-small cell lung cancer progressing after prior carboplatin-paclitaxel. Proc Am Soc Clin Oncol 1998, 17, 463a (abstr 1797)."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB9","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.1999.17.7.2081","article-title":"Gemcitabine as second-line treatment for advanced non-small cell lung cancer","volume":"17","author":"Crino","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB10","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1200\/JCO.2000.18.12.2354","article-title":"Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens","volume":"18","author":"Fossella","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/1097-0142(20000815)89:4<774::AID-CNCR9>3.0.CO;2-5","article-title":"A phase II study of paclitaxel-ifosfamide-cisplatin (PIC) combination in advanced non-small cell lung cancer","volume":"89","author":"Kosmas","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1054\/bjoc.1999.0919","article-title":"Phase I study of dose escalated paclitaxel, ifosfamide, and cisplatin combination chemotherapy in advanced solid tumours","volume":"82","author":"Kosmas","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1959","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-105-3-429","article-title":"Confidence interval for reporting results of clinical trials","volume":"105","author":"Simon","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0021-9681(61)90060-1","article-title":"The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapeutic agent","volume":"20","author":"Gehan","year":"1961","journal-title":"J. Chron. Dis."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB16","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1200\/JCO.1989.7.11.1602","article-title":"Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer","volume":"7","author":"Bonomi","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1353::AID-CNCR11>3.0.CO;2-A","article-title":"Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network phase II trial","volume":"88","author":"Hainsworth","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB18","unstructured":"Herbst RS, Khuri FR, Jung M, et al. Phase II study of combination weekly gemcitabine and vinorelbine in patients with untreated or previously treated non-small cell lung cancer. Proc Am Soc Clin Oncol 1999, 18, 462a (abstr 1782)."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB19","unstructured":"Rossi A, Perrone F, Barletta E, et al. Activity of gemcitabine in cisplatin-pretreated patients with advanced non-small cell lung cancer: a phase II trial. Proc Am Soc Clin Oncol 1999, 18, 484a (abstr 1868)."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB20","unstructured":"Reddy GR, Gandara DR, Edelman MJ, et al. Gemcitabine in platinum treated non-small cell lung cancer. Proc Am Soc Clin Oncol 1999, 18, 521a (abstr 2007)."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.annonc.a058687","article-title":"Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer","volume":"5","author":"Depierre","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB22","first-page":"1413","article-title":"Failure of vinorelbine to produce responses in pretreated non-small-cell lung cancer","volume":"14","author":"Pronzato","year":"1994","journal-title":"Anticancer Res."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB23","unstructured":"Rinaldi M, Della Gulia M., Venturo I, et al. Vinorelbine as single agent in the treatment of advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 1994, 12, 360a (abstr 1212)."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-5002(97)89303-8","article-title":"Phase III study of gemcitabine versus best supportive care in advanced non-small cell lung cancer","volume":"8","author":"Anderson","year":"1997","journal-title":"Lung Cancer"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jnci\/91.1.66","article-title":"Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer","volume":"91","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB26","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0959-8049(98)00235-4","article-title":"Vinorelbine\/gemcitabine in advanced non-small cell lung cancer (NSCLC)","volume":"34","author":"Krajnik","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB27","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1463::AID-CNCR12>3.0.CO;2-N","article-title":"Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group","volume":"86","author":"Feliu","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1023\/A:1008305017829","article-title":"Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB and IV non-small-cell lung cancer","volume":"10","author":"Isokangas","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<557::AID-CNCR10>3.0.CO;2-5","article-title":"Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma","volume":"88","author":"Lilenbaum","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.2000.18.2.405","article-title":"Phase I\/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer","volume":"18","author":"Lorusso","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(00)00419-6_BIB31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0959-8049(99)00147-1","article-title":"Ifosfamide, vinorelbine and gemcitabine in advanced non-small cell lung cancer. A phase I study","volume":"35","author":"Recchia","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(00)00419-6_BIB32","doi-asserted-by":"crossref","unstructured":"Frasci G, Lorusso V, Panza N, et al. Gemcitabine+vinorelbine yields better survival than vinorelbine alone in elderly non-small cell lung cancer patients. Final analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial. Proc Am Soc Clin Oncol 2000, 19, 485a (abstr 1895).","DOI":"10.1016\/S0169-5002(00)80185-3"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804900004196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804900004196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T07:37:24Z","timestamp":1620805044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804900004196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0959804900004196"],"URL":"https:\/\/doi.org\/10.1016\/s0959-8049(00)00419-6","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}